Intrasense, a leader in medical imaging software solutions, has recently appointed Jérôme Thiebaud as the Chief Business Officer. Thiebaud, who officially assumed his role on April 2, 2024, brings with him a wealth of experience in the healthcare industry, specifically in the field of medical imaging.
Throughout his career, Thiebaud has held key positions in prominent companies such as Philips Healthcare, GE Healthcare, and Masimo. His expertise lies in driving business development, both locally and internationally, as well as spearheading digital transformation initiatives. With a strong educational background in physical sciences from the Université de Savoie, Thiebaud is well-equipped to support Intrasense’s growth and expansion efforts on a global scale.
In his new role as Chief Business Officer, Thiebaud will oversee the Group’s sales, marketing, and services departments. His primary focus will be on driving revenue growth, enhancing the Group’s visibility, and leading the international development strategy. This appointment comes at a crucial time for Intrasense as they continue to advance their innovative solutions in key markets.
Recently, Intrasense launched the new version 2.12 of Myrian®, which incorporates cutting-edge artificial intelligence algorithms for the prostate and lung. This latest release follows certification under new European regulations, further solidifying Intrasense’s position as a leader in the medical imaging software industry. The Group is also gearing up for further advancements and innovations to cater to the evolving needs of healthcare professionals worldwide.
With Thiebaud at the helm as the Chief Business Officer, Intrasense is poised for significant commercial growth and strategic development. His appointment marks a pivotal moment in the Group’s journey towards achieving greater success in the global market.
Overall, Intrasense’s decision to appoint Jérôme Thiebaud as the Chief Business Officer signifies a strong commitment to driving innovation, growth, and excellence in the field of medical imaging software solutions. The Group’s strategic focus on expansion and advancement positions them as a key player in the healthcare industry, poised to make significant strides in the coming years.
